| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 2087.1 | 1940.5 | 1570.9 |
| Other income | 4.0 | 3.0 | 4.8 |
| Total income | 2091.1 | 1943.5 | 1575.7 |
| Profit before exceptional items & tax | 78.4 | 67.1 | 44.6 |
| Profit before tax | 78.4 | 67.1 | 44.6 |
| Net profit | 60.7 | 52.1 | 36.6 |
| Operating margin | 3.7% | 3.5% | 2.8% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | +65.80% |
|---|---|
| Net profit, quarter on quarter | +16.50% |
| Revenue, year on year | +32.90% |
| Operating profit, year on year | +86.90% |
| Operating profit, quarter on quarter | +16.10% |
BSE results filing, NSE: ENTERO. Figures extracted from the filing.
Entero Healthcare Solutions Ltd: key numbers
- Share price
- ₹1,665.00
- Market cap
- ₹7,254 Cr
- Revenue (annual)
- ₹6,591 Cr
- Net profit (annual)
- ₹115.0 Cr
- P/E (TTM)
- 57.8×Sector 54.5×
- Promoter holding
- 52.40%+0.00% QoQ
- FII holding
- 5.76%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Entero Healthcare Solutions Ltd
All →Entero Healthcare Solutions Legal & Regulatory
Entero's subsidiary Vasavi Medicare faces an INR 11.87 crore customer default. Vasavi has fully provided for the dues and plans legal recovery action.
- Value
- ₹11.87 Cr
Entero Healthcare Solutions Investor Presentation: Key Takeaways
Q2FY27 revenue Rs 2,087 Cr (+32.9% reported, +34.7% LFL), EBITDA Rs 111 Cr at 5.3% margin, PAT Rs 61 Cr (+66%). Strategy: consolidate fragmented distribution and scale MedTech (IVD, cardio-ortho).
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing reports promoter and public holdings, with no transaction or corporate event.
Entero Healthcare Solutions Board Meeting Date
Entero Healthcare Solutions scheduled a board meeting for November 04, 2026, to consider and approve unaudited financial results for the quarter ended September 30, 2026.
Entero Healthcare Solutions Other Announcement
Entero Healthcare Solutions Ltd filed its quarterly shareholding pattern under Regulation 31(1)(b) for the period ending September 2026.
Entero Healthcare Solutions Employee Stock Options
Entero Healthcare allotted 43,155 equity shares to employees upon exercise of stock options. The total consideration amounts to ₹4.24 Crore.
- Value
- ₹4.24 Cr